The Guardian5 Aug 2026Macro
Automatically composed with AI from the cited sources
No desk note for this article — the source text is below.
AstraZeneca’s rumoured takeover of Bristol Myers Squibb already looked weird, and was met with a lack of enthusiasm by shareholders